As of 2026-08-13, the EV/EBITDA ratio of Adaptive Biotechnologies Corp (ADPT) is -144.88. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ADPT's latest enterprise value is 4,069.24 mil USD. ADPT's TTM EBITDA according to its financial statements is -28.09 mil USD. Dividing these 2 quantities gives us the above ADPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 26.1x | 23.0x |
| Forward P/E multiples | 20.2x - 25.2x | 23.7x |
| Fair Price | (3.90) - (4.79) | (4.45) |
| Upside | -115.4% - -119.0% | -117.6% |
| Date | EV/EBITDA |
| 2026-08-06 | -135.54 |
| 2026-08-05 | -141.20 |
| 2026-08-04 | -140.92 |
| 2026-08-03 | -132.76 |
| 2026-07-31 | -129.70 |
| 2026-07-30 | -138.82 |
| 2026-07-29 | -129.65 |
| 2026-07-28 | -129.42 |
| 2026-07-27 | -129.53 |
| 2026-07-24 | -128.00 |
| 2026-07-23 | -128.23 |
| 2026-07-22 | -126.19 |
| 2026-07-21 | -129.76 |
| 2026-07-20 | -125.68 |
| 2026-07-17 | -131.68 |
| 2026-07-16 | -127.04 |
| 2026-07-15 | -131.57 |
| 2026-07-14 | -123.25 |
| 2026-07-13 | -120.92 |
| 2026-07-10 | -121.15 |
| 2026-07-09 | -125.34 |
| 2026-07-08 | -116.05 |
| 2026-07-07 | -119.79 |
| 2026-07-06 | -123.64 |
| 2026-07-02 | -121.89 |
| 2026-07-01 | -128.57 |
| 2026-06-30 | -123.36 |
| 2026-06-29 | -123.08 |
| 2026-06-26 | -120.58 |
| 2026-06-25 | -116.56 |
| 2026-06-24 | -111.41 |
| 2026-06-23 | -99.46 |
| 2026-06-22 | -100.25 |
| 2026-06-18 | -101.16 |
| 2026-06-17 | -96.91 |
| 2026-06-16 | -99.40 |
| 2026-06-15 | -100.76 |
| 2026-06-12 | -101.56 |
| 2026-06-11 | -107.96 |
| 2026-06-10 | -98.56 |
| 2026-06-09 | -100.20 |
| 2026-06-08 | -96.46 |
| 2026-06-05 | -97.59 |
| 2026-06-04 | -104.28 |
| 2026-06-03 | -92.44 |
| 2026-06-02 | -87.63 |
| 2026-06-01 | -88.14 |
| 2026-05-29 | -87.68 |
| 2026-05-28 | -87.91 |
| 2026-05-27 | -80.26 |